teb dergi aralık son.FH10

Turkish J. Pharm. Sci. 3(3), 151-165, 2006
HEPATOPROTECTIVE AND HYPOGLYCEMIC ACTIVITY OF
VIBURNUM LANTANA L.
Betül SEVER YILMAZ1, Gülçin SALTAN ÇÝTOÐLU1*,
M. Levent ALTUN1, Hanefi ÖZBEK2, Ýrfan BAYRAM3, Nurettin CENGÝZ4,
Çiðdem ALTINYAY1
1
Ankara University, Faculty of Pharmacy, Department of Pharmacognosy,
06100 Ankara, TURKEY
2
Yüzüncü Yýl University, Faculty of Medicine, Department of Pharmacology,
65300 Van, TURKEY
3
Yüzüncü Yýl University, Faculty of Medicine, Department of Pathology,
65300 Van, TURKEY
4
Yüzüncü Yýl University, Faculty of Medicine, Department of Histology,
65300 Van, TURKEY
Abstract
In the present study we investigated the hepatoprotective effect of the water extract of
Viburnum lantana L. (VL) leaves on carbon tetrachloride (CCl4)-induced hepatotoxicity in rats,
hypoglycemic activity and lethal doses of the same extract in mice.
Biochemical parameters of hepatic damage such as serum aspartate aminotransferase (AST),
alanine aminotransferase (ALT), alkaline phosphatase (ALP) and bilirubin concentrations were
determined. CCl4 (0.8 mL/kg i.p. for 7 days) treatment increased the serum AST, ALT, ALP and
bilirubin levels significantly as compared to controls. Treatment of animals with silibinin (50 mg/kg)
+ CCl4 (0.8 mL/kg i.p.) or VL (100 mg/kg, i.p.) + CCl4 (0.8 mL/kg i.p.) for 7 days significantly
ameliorated the levels of AST, ALT and ALP elevated by the CCl4 treatment alone. The results of
biochemical tests were also confirmed by histopathological examination. The livers of the group
treated with VL showed less balooning degeneration and apoptosis. Necrosis had not been observed
in VL group. These results suggest that, liver damage occured in VL-treated group is less than the
damage occured in silibinin-treated group.
To evaluate of hypoglicemic activity of VL, glibenclamide was used as the reference agent.
But, VL has not hypoglycemic activity in healthy and diabetic mice.
Keyword: Viburnum lantana, hepatoprotective activity, hypoglycemic activity, median lethal dose.
Vibrinum Lantana Yapraklarýnýn Hepatoprotektif ve Hipoglisemik Etkisi
Bu çalýþmada Viburnum lantana L. (VL) yapraklarýnýn sulu ekstresinin, sýçanlarda karbon
tetraklorür (CCl4) nedenli hepatotoksisite üzerine hepatoprotektif etkisi, farelerde letal dozu ve
hipoglisemik aktivitesi araþtýrýlmýþtýr.
Serum aspartat amino transferaz (AST), alanin amino transferaz (ALT), alkalin fosfataz (ALP)
ve bilirubin konsantrasyonu gibi karaciðer hasarýnýn biyokimyasal parametrelerine bakýlmýþtýr. CCl4
(0.8 mL/kg i.p., 7 gün) grubunda serum AST, ALT, ALP ve bilirubin seviyelerinin kontrol grubuyla
*corresponding author : Tel
: + 90 312 212 68 05 -2353,
Fax
: + 90 312 213 10 81
e-mail : [email protected]
151
Betül SEVER, Gülçin SALTAN ÇÝTOÐLU, M. Levent ALTUN, Hanefi ÖZBEK, Ýrfan BAYRAM, Nurettin CENGÝZ, Çiðdem ALTINYAY
kýyaslandýðýnda anlamlý seviyede arttýðý görülmüþtür. Sýçanlara silibinin (50 mg/kg)+CCl4
(0.8 mL/kg i.p.) ve VL (100 mg/kg, i.p.) + CCl4 (0.8 mL/kg i.p.) 7 gün boyunca uygulandýðýnda, tek
baþýna CCl4 uygulandýðýndaki yükselen serum AST, ALT ve ALP seviyeleri anlamlý bir þekilde
düþmüþtür. Biyokimyasal testlerin sonuçlarý histopatolojik incelemelerle de doðrulanmýþtýr. VL
uygulanan grubun karaciðerlerinde daha az balon dejenerasyonu ve apoptozis görülmüþtür. Bu grupta
da nekroz gözlenmemiþtir. Bu sonuçlar VL uygulanan gruptaki karaciðer hasarýnýn silibinin uygulanan
grupta gözlenen hasardan daha az olduðunu göstermektedir.
VL’nin hipoglisemik aktivitesini deðerlendirmek için glibenklamid referans madde olarak
kullanýlmýþtýr. Fakat VL, saðlýklý ve diyabetik farelerde hipoglisemik aktivite göstermemiþtir.
Anahtar kelimeler: Viburnum lantana, hepatoprotektif aktivite, hipoglisemik aktivite, ortalama letal
doz.
INTRODUCTION
The genus Viburnum (Caprifoliaceae) comprises more than 230 species distributed from South
America to South-East Asia, the majority of them being endemic (1).
The plant is represented by four species in the flora of Turkey; Viburnum opulus L., V. orientalis
Pallas, and V. lantana L. and V. tinus L. (2,3).
In Middle Anatolia, a traditional drink named gilaburu has been prepared from the fruits of
V. opulus. The fruit has a dark-red color and is edible. The barks of V. lantana have been used in
folk medicine as rubefiant and analgesic (4). The preventive effect of V. dilatatum on oxidative
damages was found in rats plasma, liver and stomach subjected to stress (5) and streptozotocininduced diabetic rats (6). In addition, the effect of V. dilatatum on antioxidant enzymes in plasma,
liver, stomach was examined and the results suggested that ingestion of this plant might contribute
to reduce the consumption of antioxidant enzymes, such as superoxide dismutase, catalase, glutation
peroxidase and glutation (7). The alcoholic extract of V. erubescens Wall. has been reported to
show antiviral activity (8). Some iridoid aldehytes isolated from V. luzonicum exhibited moderate
inhibitory activity against He La S3 cancer cells (9).
The genus Viburnum is known to contain triterpenoids (10-12), diterpenoids (13,14), sesquiterpenes
(15), iridoids (16-19) and polyphenols (20,21).
The obcective of this study was to determine the hepatoprotective and hypoglycemic effects
of V. lantana. These activities have not been investigated before on this species.
152
Turkish J. Pharm. Sci. 3(3), 151-165, 2006
EXPERIMENTAL
Plant material
Viburnum lantana was collected in 2005 from flowering plants near Ankara (Turkey). Voucher
specimens were kept in the Herbarium of Ankara University, Faculty of Pharmacy (AEF No
23543).
Preparation of extract
Air-dried and powdered leaves of the plant were extracted with water. The aqueous extract
was prepared by macerating 100 g of plant powder in 1000 mL of cold distilled water for 1 day.
The macerate was evaporated and lyophilized. The extract yield was 13.45g/100g (w/w).
Animals
Male and female Sprague-Dawley rats (200-250 g) and Swiss albino mice (20-24 g) were
maintained in the Animal House of Yüzüncü Yýl University, Faculty of Medicine. The animals
were breed in our institutional animal house but the lineage originally obtained from Ankara Health
Protection Institute (a governmental organisation). The animals were housed in standard cages (48
cm x 35 cm x 22 cm), at room temparature (22±2 oC) with artificial light from 7.00 am to 7.00
pm, and provided with pelleted food (Van Animal Feed Factory, Van-TURKEY) and water ad
libitum. The protocol for the study was approved by the Ethical Committee of Yüzüncü Yýl
University Faculty of Medicine Animal Breeding and Research (2005/06-02).
Drugs and Chemicals
Carbon tetrachloride (Merck, Darmstadt, Germany), olive oil (Fluka, Steinheim, Germany),
alloxan and silibinin (Sigma, Steinheim, Germany) and glibenclamide (Nobel, Ýstanbul, Turkey).
CCl4 was dissolved in olive oil and silibinin was solved in ethyl alcohol.
Acute toxicity test
Male and female mice were randomly assigned to six groups with six animals in each group.
First group was treated with isotonic saline solution (ISS) (0.9% NaCl) and considered as control
and the other five groups were treated with V. lantana given intraperitoneally (i.p.) in increasing
dosages of 0.20, 0.40, 0.80, 1.60 and 3.20 g/kg body weight. The mortality in each cage was
assessed 72 h after administration of V. lantana. The percentage mortalities were converted to
probits. Regression lines were fitted by the method of least squares and confidence limits for the
LD1, LD10, LD50, LD90 and LD99 values were calculated by the method of Litchfield and
Wilcoxon (22), and Kouadio et al (23).
153
Betül SEVER, Gülçin SALTAN ÇÝTOÐLU, M. Levent ALTUN, Hanefi ÖZBEK, Ýrfan BAYRAM, Nurettin CENGÝZ, Çiðdem ALTINYAY
Carbontetrachloride model for evaluation of antihepatotoxic activity
The carbon tetrachloride model described by Handa and Sharma (24) was used for scheduling
the dose regimen. 0.8 mL/kg, i.p. of carbon tetrachloride diluted in olive oil (1:1 dilution) was
employed for inducing liver toxicity.
Carbontetrachloride induced-hepatotoxicity
Thirty-six rats of either both sexes were distributed into six groups of six animals each. Group
I, which served as control, received isotonic saline solution (ISS) by intraperitoneal administration
(i.p.). Group II (olive oil control) received olive oil (0.8 mL/kg) i.p. once daily for 7 days. Group
III received ethanol 0.2 mL/kg, group IV received silibinin 50 mg/kg (25). Group V received
CCl4:olive oil (1:1) 0.8 mL/kg and group VI received aqueous extract of VL 100 mg/kg +
CCl4:olive oil (1:1) 0.8 mL/kg intraperitoneally (i.p.) at the same time, once daily and simultaneously
for seven days. All the animals were observed daily and any dead animals were subjected to postmortem examination to find the cause of death. The rats were killed after 24 hours from the last
examination done on the seventh day. At the end of the treatment, blood samples were collected
by direct cardiac puncture and the serum was used for the assay of the marker enzymes aspartate
aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP) and bilirubin.
Body weights of the rats were measured daily during the study. Daily changes in body weights
as percentages were recorded.
Assessment of liver function
The serum AST, ALT, ALP and bilirubin concentrations were determined with a commercial
slides using a Vitros D60 II autoanalyzer.
Histopathological examination of the liver
The livers of the experimental animals were fixed in 10 % neutral buffered-formalin prior to
routine processing in paraffin-embedded blocks. Sections (4 µm thick) were cut and stained using
Hematoxylin-eosin (HE) and Masson’s Trichrome stain. Histological damage was expressed using
the following score system; 0: absent; +:mild; ++:moderate; +++:severe.
Preparation of alloxan diabetic mice
Mice were fasted for 18 h. diabetes was induced by an ip injection of 150 mg/kg of alloxan
monohydrate in ISS. This procedure were repeated three times (26). After 7 days of the last
treatment, mice with blood glucose levels of 200 mL/dL and over were taken into the study (27).
154
Turkish J. Pharm. Sci. 3(3), 151-165, 2006
Hypoglycemic activity in diabetic mice
Animals were randomly divided into three groups of six animals each. Group I mice received
0.1 mL ISS i.p. The animals of group II were treated orally with glibenclamide, used as a standard
at a dose of 3.0 mg/kg. Group III received ip with 100 mg/kg body weight of VL. Blood glucose
levels were determined before treatment, 1, 2, 4 and 24 h after treatment by applying glucose
oxidase peroxidase method (Abbott, United Kingdom). The blood was taken from tail ven by
scalpel blade.
Hypoglycemic activity in healthy mice
The same protocol described above for healthy mice was followed. Also in this case, three
groups of six animals each were used.
Statistical analysis
Results are reported as mean±SEM (standard error of mean). Body weight changes and
histopathological findings were evaluated by Chi-square test. The total variation was analysed by
performing one-way analysis of variance (ANOVA). Tukey’s HSD (honestly significant difference),
LSD (least significant difference) test and Tamhane’s T2 tests were used for determining significance.
Probability levels of less than 0.05 were considered significant.
RESULTS
Acute toxicity
Mice have been utilized to determine the i.p. LD50 value of V. lantana. The LD50 value of
the extract was found to be 2.169 g/kg in mice. This data enabled us to select the dose to be
administrated to rats for assessing its hepatoprotective activity. The results of lethal doses are
shown in Table 1.
155
Betül SEVER, Gülçin SALTAN ÇÝTOÐLU, M. Levent ALTUN, Hanefi ÖZBEK, Ýrfan BAYRAM, Nurettin CENGÝZ, Çiðdem ALTINYAY
b
abcd
abcd
e
abcd
e
abd
The results of post-hoc Tukey’s HSD test:
a
: p<0.05 with respect to control.
b
: p<0.05 with respect to olive oil.
c
: p<0.05 with respect to ethanol.
d
: p<0.05 with respect to silibinin.
e
: p<0.05 with respect to CCl4.
a
a
a
156
Turkish J. Pharm. Sci. 3(3), 151-165, 2006
Effects of VL on AST, ALT, ALP and bilirubin levels
The results of hepatoprotective effect of VL on intoxicated rats are shown in Table 2. In the
CCl4 treated group serum AST, ALT, ALP and bilirubin levels were quite high. The VL treated
group had significantly lower levels of ALT, AST, ALP and bilirubin when compared with the
CCl4 group similar to silibinin treated group.
Effects of VL on the rat body weight
The effect of VL on the body weight of CCl4-induced rats is shown in Table 3. The percentual
daily body weight changes indicated that the CCl4-treated group and VL-group had the same
weight loss.
Histopathological Examination
Histopathological examination demonstrated that in ISS and olive oil treated liver, no alterations
were observed. But, CCl4 group (compared to ISS control and olive oil control group) induces
ballooning degeneration, centrilobular necrosis, bridging necrosis and apoptosis in hepatocytes
(Figure 1). Silibinin treated liver (compared to CCl4 control group) did show remarkable recovery
on ballooning degeneration and apoptosis (Figure 2). Histopathological examination of VL-treated
group showed less ballooning degeneration and apoptosis. Centrilobular necrosis had not been
found in VL group (Figure 3). The results of the histopathological studies are given in Table 4.
157
Betül SEVER, Gülçin SALTAN ÇÝTOÐLU, M. Levent ALTUN, Hanefi ÖZBEK, Ýrfan BAYRAM, Nurettin CENGÝZ, Çiðdem ALTINYAY
Figure 1. Numerous ballooned hepatocytes are seen in the liver (Hematoxylin-eosin stain,
original magnification, HE, X20)
Figure 2. The liver tissue of silibinin group (Hematoxylin-eosin stain, original magnification,
HE, X20)
158
Turkish J. Pharm. Sci. 3(3), 151-165, 2006
Figure 3. The liver tissue of Viburnum lantana group (Hematoxylin-eosin stain, original
magnification, HE, X10).
of
a : p>0.05 with respect to control
b : p>0.05 with respect to silibinin
c : p>0.05 with respect to CCl4
Hypoglycemic Activity
In Table 5 glibenclamide treatment significantly decreased the blood glucose levels in diabetic
mice, starting from the second hour. On the other hand, VL had no effect in terms of lowering
blood glucose. Table 6 shows that blood glucose levels of normal mice were in normal values
during the study. Only the blood sample taken in the second hour from VL-treated group was
found to have a significant higher value of blood glucose when compared with control and
glibenclamide-treated groups.
159
Betül SEVER, Gülçin SALTAN ÇÝTOÐLU, M. Levent ALTUN, Hanefi ÖZBEK, Ýrfan BAYRAM, Nurettin CENGÝZ, Çiðdem ALTINYAY
a
a
b
Data were represented as mean ± standart error of the mean.
Post-hoc LSD test:
a: p<0.05 compared to ISS group.
b: p<0.05 compared to glibenclamide group.
160
a
b
Turkish J. Pharm. Sci. 3(3), 151-165, 2006
Data were represented as mean ± standart error of the mean.
Post-hoc LSD test:
a: p<0.05 compared to ISS group.
b: p<0.05 compared to glibenclamide group.
DISCUSSION
This is the first study to show the hepatoprotective activity of VL. The intraperitoneal LD50
value of V. lantana extract was determined as 2.169 g/kg (Table 1).
When the biochemical, histopathological and body weight value results are considered, it can
be suggested that V.lantana has partially treating effect on CCl4-induced acute liver toxicity as
strong as silibinin. The results were shown in Table 2-4 and figure 1-3. Hovath et al (25). reported
that silibinin and/or vitamin E modulates the cellular immunoresponse and restores impaired liver
function following partial hepatectomy, presumably through their antioxidant capacity although
it is not clear what mechanism terminates this process .
Mohamed et al (28) was also reported the hepatoprotective activity of V. tinus L. using the
same method. In that study the levels of ALT and AST enzymes were significantly reduced by
treatment with the extract in a dose-dependant manner. Treatment with 25 mg/kg (ip) of V. tinus
extract showed no significant change in serum ALT and AST levels, while its higher dose, i.e.,
50 mg/kg caused a significant hepatoprotection, evidenced by improvement of ALT and AST
values.
161
Betül SEVER, Gülçin SALTAN ÇÝTOÐLU, M. Levent ALTUN, Hanefi ÖZBEK, Ýrfan BAYRAM, Nurettin CENGÝZ, Çiðdem ALTINYAY
In addition, the antioxidant properties of V. dilatatum THUNB. fruit squeezing solution have
also been determined (5).
The hepatic damage induced by CCl4 is well known to be mediated by its free radical metabolites
such as CCl3 and Cl3COO, which could be readily interact with unsaturated membrane lipid to
produce lipid peroxidation and/or with other critical cellular macromolecules leading to a cell
damage (29,30). Thus, it can be suggested that the potential hepatoprotective activity of VL against
CCl4–induced hepatic damage could be due to its antioxidant capacity. According to this feature
we also investigated free radical scavenging effect of V. lantana by the 1,1’-diphenyl-2-picryhydrazyl
(DPPH) scavenging and superoxide anion scavenging methods (31). The branch extracts of V.
lantana inhibited superoxide anion in a concentration dependent manner. The fruit extracts of V.
lantana did not show any scavenging effect on superoxide anion formation. V. lantana leaf extract
showed moderate scavenger effect on superoxide anion formation. All tested extracts exhibited
scavenging effect on DPPH radical. When compared with butylated hydroxytoluene (BHT), V.
lantana leaf, branch and fruit extracts showed the highest DPPH radical scavenging activities with
IC50 values of 14, 35, 52 and 85 µg/ml, respectively.
The results obtained herein also showed that VL had no hypoglycemic activity in alloxandiabetic mice (Table 5). Only the blood glucose level of the sample drawn from V. lantana group
in the second hour showed significant higher value when compared with the control and the
glibenclamide-treated groups (Table 6). But since the value (75.6 mg/dL) was found to be in
normal ranges, clinically it could not be significantly considered as pathologic.
In conclusion, the present study reveals that the water extract of V. lantana had relatively potent
hepatoprotective action in rats and had no hypoglycemic activity in mice.
REFERENCES
1.
Lobstein, A., Haan-Archipoff, G., Englert, J., Kuhry, J.G., Anton, R., “Chemotaxonomical
investigation in the genus Viburnum” Phytochemistry, 50(7), 1175-1170, 1999.
2.
Davis, P.H., Flora of Turkey and the East Aegean Islands Vol 4, pp. 543, Edinburgh University
Press, Edinburgh, 1972.
3.
Davis, P.H., Mill, R.R., Tan, K., Flora of Turkey and the East Aegean Islands Vol 10
(Supplement), pp. 154, Edinburgh University Press, Edinburgh, 1988.
4.
Baytop, T., 1999. Therapy with Medicinal Plants in Turkey, (2nd edn). pp. 210, Nobel Týp
Kitabevleri, Ýstanbul, 1999.
162
Turkish J. Pharm. Sci. 3(3), 151-165, 2006
5.
Iwai, K., Onodera, A., Matsue, H., “Antioxidant acitivity and inhibitory effect of Gamazumi
(Viburnum dilatatum THUNB.) on oxidative damage induced by water immersion restraint
stress in rats” Int. J. Food Sci. Nutr., 52(5), 443-451, 2001.
6.
Iwai, K., Onodera, A., Matsue, H., “Inhibitory effects of Viburnum dilatatum Thunb.
(gamazumi) on oxidation and hyperglycemia in rats with streptozocin-induced diabetes” J.
Agric. Food Chem., 52(4), 1002-1007, 2004.
7.
Kim, M., Iwai, K., Matsue, H., “Phenolic compositions of Viburnum dilatatum Thunb. Fruits
and their antiradical properties” J. Food Compos. Anal., 18(8), 789-802, 2005.
8.
Dhar, M.L., Dhar, M.M., Dhawan, B.N., et al., “Screening of Indian plants for biological
activity” Indian J. Exp. Biol., 6, 232-247, 1968.
9.
Fukuyama, Y., Minoshima, Y., Kishimoto, Y., Chen, I.S., Takahashi, H., Esumi, T.,
“Cytotoxic iridoid aldehydes from Taiwanese Viburnum luzonicum” Chem. Pharm. Bull.
(Tokyo), 53(1), 125-127, 2005.
10. Kagawa, M., Minami, H., Nakahara, M., Takahashi, H., Takaoka, S., Fukuyama, Y.,
“Oleanane-type triterpenes from Viburnum awabuki” Phytochemistry, 47(7), 1337-1341,
1998.
11. Machida, K., Kikuchi, M., “Viburnols: Six novel triterpenoids from Viburnum
dilatatum” Tetrahedron Lett., 38(4), 571-574, 1997.
12. Fukuyama, Y., Minami, H., Fujii, H., Tajima, M., “Triterpenoids from Viburnum suspensum”
Phytochemistry, 60(8), 765-768, 2002.
13. Kubo, M., Chen, I.S., Fukuyama, Y., “Vibsane-type diterpenes from Taiwanese Viburnum
odoratissimum” Chem. Pharm. Bull. (Tokyo), 49(2), 242-245, 2001.
14. Fukuyama, Y., Kubo, M., Minami, H., Yuasa, H., Matsuo, A., Fujii, T., Morisaki, M.,
Harada, K., “Rearranged vibsane-type diterpenes from Viburnum awabuki and phytochemical
reaction of Vibsanin B” Chem. Pharm. Bull. (Tokyo), 53(1), 72-80, 2005.
15. Fukuyama, Y., Minami, H., Ichikawa, R., Takeuchi, K., Kodama, M., “Hydroperoxylated
guaiane-type sesquiterpenes from Viburnum awabuki” Phytochemistry, 42(3), 741-746, 1996.
16. Iwagawa, T., Hase, T., “An iridoid acetylalloside from Viburnum japonicum”
Phytochemistry, 25(5), 1227-1229, 1986.
163
Betül SEVER, Gülçin SALTAN ÇÝTOÐLU, M. Levent ALTUN, Hanefi ÖZBEK, Ýrfan BAYRAM, Nurettin CENGÝZ, Çiðdem ALTINYAY
17. Iwagawa, T., Yaguchi, S., Hase, T., “Iridoid glucosides from Viburnum suspensum”
Phytochemistry, 29(1), 310-312, 1990.
18. Çalýþ, Ý., Yürüker, A., Rüegger, H., Wright, A.D., Sticher, O., “Lantanoside, a monocyclic
C10 iridoid glucoside from Viburnum lantana” Phytochemistry, 38(1), 163-165, 1995.
19. Tomassini, L., Foddai, S., Nicoletti, M., Cometa, M.F., Palazzino, G., Galeffi, C., “Iridoid
glucosides from Viburnum ayavacense” Phytochemistry, 46(5), 901-905, 1997.
20. Parveen, M., Khan, M.S., Ilyas, S., Ilyas, M., “Luteolin 3’-xylosyl(1›2) glucoside from
Viburnum grandifolium” Phytochemistry, 49(8), 2535-2538, 1998.
21. Lobstein, A., Weniger, B., Malécot, V., Um, B.H., Alzate, F., Anton, R., “Polyphenolic
content of two Colombian Viburnum species (Caprifoliaceae)” Biochem. Syst.Ecol., 31(1),
95-97, 2003.
22. Litchfield, J.T., Wilcoxon, F.W.J., “A simplified method of evaluating dose-effect experiments”
J. Pharmacol. Exp. Ther., 96, 99-113, 1949.
23. Kouadio, F., Kanko, C., Juge, M., et al., “Analgesic and antiinflammatory activities of an
extract from Parkia biglobosa used in traditional medicine in the Ivory Coast” Phytother.
Res., 14, 635-637, 2000.
24. Handa, S.S., Sharma, A., “Hepatoprotective activity of andrographolide from Andrographis
paniculata against carbontetrachloride” Indian J. Med. Res. [B], 92, 276-283, 1990.
25. Horváth, M.É., González-Cabello, R., Blázovics, A., Looij, M., Barta, I., Müzes, G.,
Gergely, P., Fehér, J., “Effect of silibinin and vitamin E on restoration of cellular immune
response after partial hepatectomy” J. Ethnopharmacol., 77, 227-232, 2001.
26. Rodriguez, H., Perez, R.M., Muñoz, H., Perez, C., Miranda, R., “Inducción de diabetes
en raton por medio de aloxana” Acta. Med., XI, 33-36, 1975.
27. Singh, S.N., Vats, P., Suri, S., et al., “Effect of an antidiabetic extract of Catharanthus roseus
on enzymic activities in streptozotocin induced diabetic rats” J. Ethnopharmacol., 76, 269–277,
2001.
28. Mohamed, M.A., Mohamed, S.A., Moharram, F.A., El-Sayed, M.M., Baiuomy, A.R.,
“Phytochemical constituents and hepatoprotective avtivity of Viburnum tinus. Phytochemistry,
66, 2780-2786, 2005.
29. Snyder, R., Andrews, L.S., Toxic effects of solvents and vapors. In: Klassen, CD (Ed.),
164
Turkish J. Pharm. Sci. 3(3), 151-165, 2006
Toxicology: The Basic Science of Poissons. pp. 737-772, Mc Graw-Hill, New York, 1996.
30. Özbek, H., Çitoðlu, G.S., Dülger, H., Uðraþ, S., Sever, B., “Hepatoprotective and anti
inflammatory activities of Ballota glandulossima” J. Ethnopharmacol., 95, 143-149, 2004.
31. Çitoðlu, G.S., Altun, M.L., Sever, B.S., Gençarslan, G., Çoban, T., “Free radical scavenging
effects of Viburnum opulus L. and Viburnum lantana L. species growing in Turkey. 8th Int.
Symp. Pharm. Sci. Proceed., p 226, Ankara, June 13-16, 2006.
received: 12.04.2006
accepted: 14.11.2006
165